Promising drug candidate offers new hope for rare eye infection – Acanthamoeba Keratitis
A drug candidate developed through collaborative research between UCL and Moorfields Eye Hospital is proving highly effective in treating Acanthamoeba keratitis (AK), a rare and sight-threatening eye infection.